+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Preclinical CRO Market - Global Forecast 2026-2032- Product Image
Preclinical CRO Market - Global Forecast 2026-2032- Product Image
New

Preclinical CRO Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454997
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preclinical contract research organization (CRO) market is undergoing a pivotal transformation, shaped by scientific progress, operational priorities, and shifting collaboration dynamics. Senior decision-makers must now evaluate partnership structures and technology adoption to secure continued commercial growth and regulatory alignment.

Market Snapshot: Preclinical CRO Market Size and Outlook

The Preclinical CRO Market is projected to expand from USD 13.61 billion in 2025 to USD 14.55 billion in 2026, reaching a forecasted value of USD 22.55 billion by 2032, with a CAGR of 7.47%. This robust pace results from high demand for advanced translational models, broadening implementation of digital and automated laboratories, and heightened focus on operational continuity. Global and regional alignment—spanning compliance, talent strategies, and local supply chain integration—has become critical for sponsors aiming to streamline their development and commercialization roadmaps.

Scope & Segmentation of the Preclinical CRO Market

  • Service Offerings: Encompass bioanalytical services, clinical pathology, toxicology, safety pharmacology, and integrated regulatory dossier preparation; each segment addresses distinct phases of preclinical evaluation and regulatory submission.
  • Development Stages: Include early high-throughput lead generation, lead optimization, and GLP-compliant preclinical testing, forming the backbone for progression into first-in-human clinical trials.
  • Model Types: Cover patient-derived organoids, patient-derived xenograft models, plus a spectrum of established in vitro and in vivo systems, all built for increased translational accuracy and regulatory engagement.
  • Therapeutic Areas: Focus on oncology, neurology—such as Alzheimer’s and Parkinson’s disease—cardiology, and broad indications with tailored assay designs for each unique endpoint.
  • End Users: Serve pharmaceutical firms, biotechnology innovators, academic centers, and research institutes, all of which shape procurement needs and preferred contract structures based on development priorities.
  • Geography: Spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, each region reflecting differing regulatory landscapes, workforce capabilities, and logistical requirements.
  • Technologies: Highlight laboratory automation, enhanced digital data management, advanced assay deployment, and secure operational infrastructures for data protection and process efficiency.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Partner selection increasingly weights scientific knowledge against operational flexibility to ensure agility in responding to evolving risk and growth scenarios.
  • Innovative preclinical models, such as organoids and xenograft-based systems, are extending the precision of translational research and influencing regulatory conversations.
  • Automated and digitized laboratory workflows are accelerating study turnaround and driving the need for robust, compliant data management across all project phases.
  • Sponsors are moving toward full-service partners who can integrate critical data streams—bioanalytical, pharmacokinetic/pharmacodynamic, and safety—into complete regulatory filings.
  • Competitive differentiation now rests on the breadth and specialization of assay capabilities and the use of validated models aligned with therapeutic trends.
  • Distinct regional requirements, such as compliance in Europe or cost-focused models in Asia-Pacific, necessitate precise sourcing and market entry tactics for resilient operations.

Tariff Impact: Adapting Procurement and Contracts in 2025

Tariff changes in 2025 introduce notable complexity to procuring laboratory equipment, consumables, and reagents. Companies are responding by diversifying supplier portfolios, insourcing critical assay components, and employing risk-sharing clauses in service contracts. Adopting scenario-based supply strategies and local sourcing approaches has become essential for mitigating escalating costs, ensuring ongoing compliance, and protecting research timelines from external disruptions.

Methodology & Data Sources

This analysis combines primary interviews with R&D, procurement, and operations leaders, supported by comprehensive reviews of scientific literature, regulatory guidance, and current patent filings. Standard evaluation frameworks and triangulated analytics underpin the reliability of conclusions drawn for this report.

Why This Report Matters

  • Supports executives in identifying CRO partners who align operational, scientific, and commercial objectives, minimizing procurement and supply chain vulnerabilities.
  • Delivers actionable perspectives on technology integration and procurement approaches vital for maintaining project timelines and meeting regulatory expectations.
  • Empowers better decision-making for vendor selection and strategic investments within a continually evolving regulatory and technological landscape.

Conclusion

With evolving scientific, operational, and strategic targets, senior leaders who adapt to these market dynamics will maintain an edge in preclinical outsourcing. Market success depends on the integration of modernization, resilience, and cross-functional alignment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Preclinical CRO Market, by Service Type
8.1. Bioanalytical Services
8.2. Clinical Pathology Services
8.3. Pharmacokinetics & Pharmacodynamics Testing
8.4. Safety Pharmacology
8.5. Toxicology Testing
9. Preclinical CRO Market, by Stage Of Development
9.1. Lead Generation
9.2. Lead Optimization
9.3. Preclinical Development
10. Preclinical CRO Market, by Model Type
10.1. Patient Derived Organoid (PDO) Model
10.2. Patient Derived Xenograft Model
11. Preclinical CRO Market, by Application
11.1. Cardiology
11.1.1. Cardiac Hypertrophy Treatments
11.1.2. Cardiovascular Disease Research
11.1.3. Heart Failure Studies
11.2. Neurology
11.2.1. Alzheimer's Research
11.2.2. Cognitive Disorder Treatments
11.2.3. Parkinson's Disease Studies
11.3. Oncology
11.3.1. Chemotherapy Research
11.3.2. Immunotherapy Studies
12. Preclinical CRO Market, by End User
12.1. Academic & Research Institutes
12.2. Biotechnology Companies
12.3. Pharmaceutical Companies
13. Preclinical CRO Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Preclinical CRO Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Preclinical CRO Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Preclinical CRO Market
17. China Preclinical CRO Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 10x Genomics, Inc.
18.6. AmplifyBio LLC
18.7. Atuka Inc.
18.8. BenchSci
18.9. Biotrofix, Inc.
18.10. Celerion Holdings, Inc.
18.11. Charles River Laboratories International, Inc.
18.12. Diag2Tec SAS
18.13. Eurofins Scientific SE
18.14. F. Hoffmann-La Roche Ltd.
18.15. Genesis Biotechnology Group, LLC
18.16. Hera Biolabs Inc.
18.17. ICON PLC
18.18. ImQuest BioSciences Inc. by Cytocom, Inc.
18.19. Inotiv, Inc.
18.20. Intertek Group PLC
18.21. IQVIA Inc.
18.22. JSR Corporation
18.23. Jubilant Biosys Ltd.
18.24. Laboratory Corporation of America Holding
18.25. MLM Medical Labs GmbH
18.26. Parexel International Corporation.
18.27. Phenos GmbH
18.28. PPD by Thermo Fisher Scientific Inc.
18.29. REPROCELL Inc.
18.30. Sanofi S.A.
18.31. SCiAN Services Inc.
18.32. SGS SA
18.33. Syneos Health, Inc.
18.34. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PRECLINICAL CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PRECLINICAL CRO MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYTICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYTICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CLINICAL PATHOLOGY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CLINICAL PATHOLOGY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CLINICAL PATHOLOGY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PHARMACOKINETICS & PHARMACODYNAMICS TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PHARMACOKINETICS & PHARMACODYNAMICS TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PHARMACOKINETICS & PHARMACODYNAMICS TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SAFETY PHARMACOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SAFETY PHARMACOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PRECLINICAL CRO MARKET SIZE, BY LEAD GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PRECLINICAL CRO MARKET SIZE, BY LEAD GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PRECLINICAL CRO MARKET SIZE, BY LEAD GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PRECLINICAL CRO MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PRECLINICAL CRO MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PRECLINICAL CRO MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PATIENT DERIVED ORGANOID (PDO) MODEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PATIENT DERIVED ORGANOID (PDO) MODEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PATIENT DERIVED ORGANOID (PDO) MODEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PATIENT DERIVED XENOGRAFT MODEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PATIENT DERIVED XENOGRAFT MODEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PATIENT DERIVED XENOGRAFT MODEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIAC HYPERTROPHY TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIAC HYPERTROPHY TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIAC HYPERTROPHY TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEART FAILURE STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEART FAILURE STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEART FAILURE STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ALZHEIMER'S RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ALZHEIMER'S RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ALZHEIMER'S RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PRECLINICAL CRO MARKET SIZE, BY COGNITIVE DISORDER TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PRECLINICAL CRO MARKET SIZE, BY COGNITIVE DISORDER TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PRECLINICAL CRO MARKET SIZE, BY COGNITIVE DISORDER TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PARKINSON'S DISEASE STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PARKINSON'S DISEASE STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PARKINSON'S DISEASE STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CHEMOTHERAPY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CHEMOTHERAPY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CHEMOTHERAPY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOTHERAPY STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOTHERAPY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOTHERAPY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PRECLINICAL CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. EUROPE PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 122. EUROPE PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 127. EUROPE PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 139. AFRICA PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 140. AFRICA PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 141. AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. AFRICA PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 143. AFRICA PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 145. AFRICA PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. ASEAN PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASEAN PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 159. ASEAN PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 160. ASEAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. ASEAN PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 162. ASEAN PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 164. ASEAN PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. GCC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GCC PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 167. GCC PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 168. GCC PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 169. GCC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. GCC PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 171. GCC PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 172. GCC PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 173. GCC PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. BRICS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. BRICS PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 185. BRICS PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 186. BRICS PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 187. BRICS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. BRICS PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 189. BRICS PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 190. BRICS PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 191. BRICS PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. G7 PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. G7 PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 194. G7 PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 195. G7 PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 196. G7 PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. G7 PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 198. G7 PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 199. G7 PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 200. G7 PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. NATO PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. NATO PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 203. NATO PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 204. NATO PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 205. NATO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. NATO PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 207. NATO PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 208. NATO PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 209. NATO PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES PRECLINICAL CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. CHINA PRECLINICAL CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 222. CHINA PRECLINICAL CRO MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 223. CHINA PRECLINICAL CRO MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 224. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. CHINA PRECLINICAL CRO MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 226. CHINA PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 227. CHINA PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 228. CHINA PRECLINICAL CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Preclinical CRO market report include:
  • 10x Genomics, Inc.
  • AmplifyBio LLC
  • Atuka Inc.
  • BenchSci
  • Biotrofix, Inc.
  • Celerion Holdings, Inc.
  • Charles River Laboratories International, Inc.
  • Diag2Tec SAS
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Genesis Biotechnology Group, LLC
  • Hera Biolabs Inc.
  • ICON PLC
  • ImQuest BioSciences Inc. by Cytocom, Inc.
  • Inotiv, Inc.
  • Intertek Group PLC
  • IQVIA Inc.
  • JSR Corporation
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America Holding
  • MLM Medical Labs GmbH
  • Parexel International Corporation.
  • Phenos GmbH
  • PPD by Thermo Fisher Scientific Inc.
  • REPROCELL Inc.
  • Sanofi S.A.
  • SCiAN Services Inc.
  • SGS SA
  • Syneos Health, Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.55 Billion
Forecasted Market Value ( USD ) by 2032 $ 22.55 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Preclinical CRO Market Report 2025 - Product Image

Preclinical CRO Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Preclinical CRO Market - Global Strategic Business Report - Product Image

Preclinical CRO Market - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Oncology Based In-Vivo CRO Market - Global Forecast 2026-2032 - Product Image

Oncology Based In-Vivo CRO Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Preclinical CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Preclinical CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Preclinical CRO Market Size, Share & Trends Analysis Report by Service (Toxicology Testing, Bioanalysis & DMPK Studies, Chemistry), Model Type, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Preclinical CRO Market Size, Share & Trends Analysis Report by Service (Toxicology Testing, Bioanalysis & DMPK Studies, Chemistry), Model Type, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From

About the Preclinical CRO Market

The Preclinical CRO market is a subset of the Drug Discovery industry, focusing on the preclinical stages of drug development. Preclinical CROs provide services such as drug safety testing, pharmacology studies, and toxicology studies. These services are used to assess the safety and efficacy of potential drugs before they are tested in humans. Preclinical CROs also provide services such as drug metabolism and pharmacokinetics, which are used to understand how a drug is absorbed, distributed, metabolized, and eliminated in the body. Preclinical CROs are an important part of the drug discovery process, as they provide the data needed to move a drug candidate forward in the development process. Preclinical CROs are also used to reduce the cost and time associated with drug development, as they can provide the data needed to make decisions quickly and efficiently. Some companies in the Preclinical CRO market include Charles River Laboratories, WuXi AppTec, Covance, PRA Health Sciences, and Envigo. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.